Thierry Dorval

Head of Data Sciences & Data Management - Servier

Thierry Dorval received a Ph.D. in image analysis and Artificial Intelligence from University Pierre & Marie Curie and then joined the institut Pasteur Korea in 2005 as a group leader specialized in High Content Screening applied to cellular differentiation and toxicity prediction.


In 2012 he joined AstraZeneca, where his activities were about developing and advising on quantitative image and data analysis solutions in support of high content phenotypic screening.


In 2015 he joined Servier, France, to lead the Data Sciences & Data Management pole of activities where he is in charge of optimizing the early stages of the drug discovery by taking advantage of cutting-edge computational approaches. This includes usage of Artificial Intelligence, knowledge graph database and RNA sequences design

Thierry Dorval


  • Wednesday - May 10, 2023 - 16:10

    Coordination and Optimisation of internal drug development data alongside external data sources

  • Wednesday - May 10, 2023 - 16:40

    Panel discussion: How Global Pharma is using AI and Machine Learning for success?

    • Innovation in Big-Pharma
    • AI enabled business models in R&D
    • Achieving full potential of AI to boost Drug Discovery and Development
    • AI has the capacity to radically reduce the uncertainty in both early and late-stage drug discovery and development


Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now